These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 17168412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanism of action of niacin.
    Kamanna VS, Kashyap ML.
    Am J Cardiol; 2008 Apr 17; 101(8A):20B-26B. PubMed ID: 18375237
    [Abstract] [Full Text] [Related]

  • 3. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J.
    Arch Intern Med; 2004 Apr 12; 164(7):697-705. PubMed ID: 15078639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of immediate-release niacin in patients with ischemic cardiopathy. Experience of the Instituto Nacional de Cardiología "Ignacio Chávez"].
    Morato Hernández ML, Ichazo Cerro MS, Alvarado Vega AG, Zamora González J, Cardoso Saldaña GC, Posadas Romero C.
    Arch Inst Cardiol Mex; 2000 Apr 12; 70(4):367-76. PubMed ID: 11075282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Niacin for lipid disorders. Indications, effectiveness, and safety.
    Brown WV.
    Postgrad Med; 1995 Aug 12; 98(2):185-9, 192-3. PubMed ID: 7630846
    [Abstract] [Full Text] [Related]

  • 12. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS.
    Angiology; 2009 Aug 12; 60(1):93-8. PubMed ID: 19019838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders.
    Vo AN, Kashyap ML.
    Expert Rev Cardiovasc Ther; 2008 Nov 12; 6(10):1303-10. PubMed ID: 19018682
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M, Oguchi A, Nagamia S, Vaccari CS, Hammoud R, Umpierrez GE, Khan BV.
    Int J Clin Pract; 2007 Nov 12; 61(11):1942-8. PubMed ID: 17935553
    [Abstract] [Full Text] [Related]

  • 17. Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials.
    Ahmed MH.
    Ren Fail; 2010 Jun 12; 32(5):642-6. PubMed ID: 20486851
    [Abstract] [Full Text] [Related]

  • 18. Safety of niacin and simvastatin combination therapy.
    Bays H.
    Am J Cardiol; 2008 Apr 17; 101(8A):3B-8B. PubMed ID: 18375239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
    Maccubbin D, Koren MJ, Davidson M, Gavish D, Pasternak RC, Macdonell G, Mallick M, Sisk CM, Paolini JF, Mitchel Y.
    Am J Cardiol; 2009 Jul 01; 104(1):74-81. PubMed ID: 19576324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.